Science Explorer Back to mapMap

Most cited papers from NeoGenomics (United States)

What are the most cited papers from NeoGenomics (United States)?

The most cited paper from NeoGenomics (United States) is "Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project" (Diana M. Merino et al., 2020), with 516 citations. Next come "Identification of a low–molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice" (407) and "Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia" (347).

Showing 50 of 61 papers. Every paper with more than 38 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project Diana M. Merino et al. · Journal for ImmunoTherapy of Cancer Open access Mar 2020 516
2 Identification of a low–molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice Maxime Cazorla, Joël Prémont, André Mann et al. · Journal of Clinical Investigation Open access 18 Apr 2011 407
3 Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia Inhye E. Ahn, Chingiz Underbayev, Adam Albitar et al. · Blood Open access 3 Jan 2017 347
4 Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models James G. Taylor et al. · Journal of Clinical Investigation Open access 5 Oct 2009 322
5 Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry Donald H. Chace, Steven L Hillman, Johan L.K. Van Hove et al. · Clinical Chemistry Nov 1997 284
6 Electrospray Tandem Mass Spectrometry for Analysis of Acylcarnitines in Dried Postmortem Blood Specimens Collected at Autopsy from Infants with Unexplained Cause of Death Donald H. Chace, James Clyde DiPerna, Brenda L. Mitchell et al. · Clinical Chemistry Jul 2001 247
7 Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Mutations Identified by MS/MS-Based Prospective Screening of Newborns Differ from Those Observed in Patients with Clinical Symptoms: Identification and Characterization of a New, Prevalent Mutation That Results in Mild MCAD Deficiency* Brage Storstein Andresen, Steve F. Dobrowolski, Linda P. O’Reilly et al. · The American Journal of Human Genetics Open access Jun 2001 234
8 Mass Spectrometry in the Clinical Laboratory Donald H. Chace · Chemical Reviews Review 9 Jan 2001 211
9 The Application of Tandem Mass Spectrometry to Neonatal Screening for Inherited Disorders of Intermediary Metabolism Donald H. Chace, Theodore A. Kalas, Edwin W. Naylor · Annual Review of Genomics and Human Genetics Review 26 Aug 2002 210
10 Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project Diana Merino Vega et al. · Annals of Oncology Open access Oct 2021 186
11 Use of phenylalanine-to-tyrosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24 hours Donald H. Chace, John E. Sherwin, Steven L Hillman et al. · Clinical Chemistry Dec 1998 183
12 Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL Ziju Y. Xu-Monette et al. · Cancer Immunology Research 11 Feb 2019 181
13 Automated Tandem Mass Spectrometry for Mass Newborn Screening for Disorders in Fatty Acid, Organic Acid, and Amino Acid Metabolism Edwin W. Naylor, Donald H. Chace · Journal of Child Neurology Nov 1999 168
14 Medium Chain Acyl-CoA Dehydrogenase Deficiency in Pennsylvania: Neonatal Screening Shows High Incidence and Unexpected Mutation Frequencies Rana Ziadeh, Eric P. Hoffman, David N. Finegold et al. · Pediatric Research May 1995 167
15 The future is big graphs Sherif Sakr et al. · Communications of the ACM Open access 24 Aug 2021 159
16 Are dopaminergic genes involved in a predisposition to pathological aggression? Thomas J.H. Chen, Kenneth Blum, Daniel Mathews et al. · Medical Hypotheses 2005 157
17 On the origins of drug polypharmacology Xavier Jalencas, Jordi Mestres · MedChemComm 29 Oct 2012 143
18 Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American experts Nicholas James Short, Elias Joseph Jabbour, Maher X. Albitar et al. · American Journal of Hematology Open access 5 Nov 2018 139
19 SNPchiMp v.3: integrating and standardizing single nucleotide polymorphism data for livestock species Ezequiel Luís Nicolazzi, Andrea Caprera, Nelson Nazzicari et al. · BMC Genomics Open access 9 Apr 2015 139
20 Recoveries of Phenylalanine from Two Sets of Dried-Blood-Spot Reference Materials: Prediction from Hematocrit, Spot Volume, and Paper Matrix Barbara W Adam, Joseph R. Alexander, S. Jay Smith et al. · Clinical Chemistry 2000 138
21 NTRK insights: best practices for pathologists Jaclyn Frances Hechtman · Modern Pathology Open access 16 Sep 2021 126
22 Parthenolide Inhibits Tubulin Carboxypeptidase Activity Xavier Fonrose, Fréderic Ausseil, Emmanuelle Soleilhac et al. · Cancer Research Open access Apr 2007 126
23 Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus Mathilda Mandel, Michael Gurevich, Rachel Pauzner et al. · Clinical & Experimental Immunology Open access 31 Aug 2004 120
24 When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regions Andrew M. Bradbury et al. · mAbs Open access 27 Feb 2018 119
25 Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12 Marcel Romanos et al. · Molecular Psychiatry 26 Feb 2008 112
26 Fibrin-associated EBV-positive Large B-Cell Lymphoma Daniel F. Boyer, Penelope A McKelvie, Laurence de Leval et al. · The American Journal of Surgical Pathology 10 Feb 2017 108
27 Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic Model Inhye E. Ahn, Xin Tian, David Ipe et al. · Journal of Clinical Oncology Open access 7 Oct 2020 106
28 Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues Kate E. Grimm, Dennis P. O’Malley · Annals of Diagnostic Pathology Oct 2018 104
29 Rapid Diagnosis of Methylmalonic and Propionic Acidemias Donald H. Chace, James Clyde DiPerna, Theodore A. Kalas et al. · Clinical Chemistry Nov 2001 100
30 Validation of Accuracy-based Amino Acid Reference Materials in Dried-Blood Spots by Tandem Mass Spectrometry for Newborn Screening Assays Donald H. Chace, Barbara W Adam, S. Jay Smith et al. · Clinical Chemistry Open access Aug 1999 89
31 Antitumor Activity of Pyridocarbazole and Benzopyridoindole Derivatives that Inhibit Protein Kinase CK2 Renaud Prudent, Virginie Moucadel, Chi-Hung Nguyen et al. · Cancer Research 30 Nov 2010 82
32 Epstein-Barr virus (EBV)–associated lymphoid proliferations, a 2018 update Sherif A. Rezk, Xiaohui Zhao, Lawrence Martin Weiss · Human Pathology 6 Jun 2018 81
33 An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease Timothy James Kendall, Maria Jiménez Ramos, Frances S Turner et al. · Nature Medicine Open access 30 Oct 2023 80
34 Immunohistochemical detection of PD-L1 among diverse human neoplasms in a reference laboratory: observations based upon 62,896 cases Dennis P. O’Malley, Yuhang Yang, Saskia Boisot et al. · Modern Pathology Open access 13 Feb 2019 80
35 Laboratory integration and utilization of tandem mass spectrometry in neonatal screening: a model for clinical mass spectrometry in the next millennium DH Chace, JC DiPerna, EW Naylor · Acta Paediatrica Dec 1999 69
36 Time-Response Evaluation by Transcriptomics of Methylmercury Effects on Neural Differentiation of Murine Embryonic Stem Cells Peter T. Theunissen, Jeroen L. A. Pennings, Joshua F. Robinson et al. · Toxicological Sciences Open access 25 May 2011 68
37 Scientifically unfounded precaution drives European Commission’s recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles Daniel Reto Dietrich, Sonja von Aulock, Hans W.J. Marquardt et al. · Chemico-Biological Interactions Open access 4 Jul 2013 67
38 A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignancies Cory Batenchuk, Maher X. Albitar, Kim E. Zerba et al. · Journal of Clinical Pathology Open access Oct 2018 64
39 The nine-banded armadillo (Dasypus novemcinctus) is naturally infected with Sarcocystis neurona Susan M. Tanhauser, M.A Cheadle, E.T Massey et al. · International Journal for Parasitology Apr 2001 58
40 Analysis of real-world PD-L1 IHC 28-8 and 22C3 pharmDx assay utilisation, turnaround times and analytical concordance across multiple tumour types Gabriel S. Krigsfeld, Emily A. Prince, James L. Pratt et al. · Journal of Clinical Pathology Open access 26 Jun 2020 56
41 American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma Dennis P. O’Malley, Ahmet Doǧan, Yuri D. Fedoriw et al. · Annals of Diagnostic Pathology 10 Feb 2019 56
42 Correlation of MET gene amplification and TP53 mutation with PD-L1 expression in non-small cell lung cancer Maher X. Albitar, Sucha Sudarsanam, Wanlong Ma et al. · Oncotarget Open access 8 Feb 2018 56
43 Rapid β-Globin Genotyping by Multiplexing Probe Melting Temperature and Color Mark G. Herrmann, Steven F. Dobrowolski, Carl T. Wittwer · Clinical Chemistry Mar 2000 56
44 The life and death of the germinal center Eric J. Gars, Alexandra Butzmann, Robert Shigeo Ohgami et al. · Annals of Diagnostic Pathology 13 Nov 2019 54
45 Single-cell heterogeneity in ductal carcinoma in situ of breast Michael J. Gerdes, Yesim Gökmen‐Polar, Yunxia Sui et al. · Modern Pathology Open access 17 Nov 2017 54
46 Human cyclin C protein is stabilized by its associated kinase cdk8, independently of its catalytic activity Caroline Barette, Isabelle Jariel‐Encontre, Marc Piechaczyk et al. · Oncogene Feb 2001 54
47 Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study Marc Oliva et al. · Journal for ImmunoTherapy of Cancer Open access Oct 2021 53
48 Body image concerns in women with polycystic ovary syndrome: a systematic review and meta-analysis Meri Davitadze, Kashish Malhotra, Halimah Khalil et al. · European Journal of Endocrinology ReviewOpen access Aug 2023 52
49 High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disaster Sakshi Jasra et al. · Nature Medicine Open access Mar 2022 50
50 Integration of genomics and transcriptomics predicts diabetic retinopathy susceptibility genes Andrew D. Skol, Segun C. Jung, Ana Marija Sokovic et al. · eLife Open access 9 Nov 2020 49

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.